Back to HomeBeta

ICD-10 Coding for Prostate Cancer(C61, Z85.46, Z08)

Complete ICD-10-CM coding and documentation guide for Prostate Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Prostatic NeoplasmMalignant Neoplasm of ProstateCancer of ProstateProstate CarcinomaCarcinoma of the ProstateProstate Adenocarcinomacarcinoma prostateadenocarcinoma the prostate

Related ICD-10 Code Ranges

Complete code families applicable to Prostate Cancer

C61Primary Range

Malignant neoplasm of prostate

Primary code for active prostate cancer cases.

Personal history of malignant neoplasm of prostate

Used for patients with a history of prostate cancer.

Encounter for follow-up examination after completed treatment for malignant neoplasm

Used for follow-up visits post-treatment.

Secondary malignant neoplasm of genital organs

Used for metastasis to genital organs.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C61Malignant neoplasm of prostateUse when prostate cancer is currently active or under treatment.
  • PSA levels indicating active disease
  • Biopsy results confirming malignancy
Z85.46Personal history of malignant neoplasm of prostateUse when the patient has a history of prostate cancer with no current evidence of disease.
  • Documentation of no evidence of disease
Z08Encounter for follow-up examination after completed treatment for malignant neoplasmUse for follow-up visits after cancer treatment has been completed.
  • Completed treatment with follow-up plan

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for prostate cancer

Essential facts and insights about Prostate Cancer

The ICD-10 code for active prostate cancer is C61, used when the cancer is currently active or under treatment.

Primary ICD-10-CM Codes for prostate cancer

Malignant neoplasm of prostate
Billable Code

Decision Criteria

clinical Criteria

  • Active treatment or surveillance status

Applicable To

  • Prostate cancer under active treatment
  • Prostate cancer under surveillance

Excludes

  • Benign prostatic hyperplasia
  • Prostatic intraepithelial neoplasia

Clinical Validation Requirements

  • PSA levels indicating active disease
  • Biopsy results confirming malignancy

Code-Specific Risks

  • Misclassification of active vs. historical cancer

Coding Notes

  • Ensure documentation specifies active treatment or surveillance status.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Follow-up examination after treatment

Z08
Use for follow-up visits after treatment completion.

Personal history of malignant neoplasm of prostate

Z85.46
Use when documenting history of prostate cancer.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Secondary malignant neoplasm of genital organs

C79.82
Used when metastasis to genital organs is confirmed.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Prostate Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C61.

Impact

Clinical: Misrepresentation of patient's current health status., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Verify current treatment status, Review PSA and biopsy results

Impact

Reimbursement: Incorrect classification can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.

Mitigation Strategy

Use C61 for active cancer and Z85.46 for historical cases.

Impact

Incorrect coding of active cancer as historical.

Mitigation Strategy

Regular training on coding guidelines.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Prostate Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Prostate Cancer

Use these documentation templates to ensure complete and accurate documentation for Prostate Cancer. These templates include all required elements for proper coding and billing.

Active Surveillance

Specialty: Urology

Required Elements

  • PSA levels
  • Biopsy results
  • Surveillance plan

Example Documentation

Patient on active surveillance with PSA monitoring every 6 months, last PSA 4.2 ng/mL.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Prostate cancer managed observationally.
Good Documentation Example
Active surveillance protocol: PSA q3mo, MRI fusion biopsy 12/2024 showed Gleason 3+4 in left peripheral zone (5/12 cores positive).
Explanation
The good example provides specific details about the surveillance plan and biopsy results.

Need help with ICD-10 coding for Prostate Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more